These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Conformational study of lysergic acid derivatives in relation to their hallucinogenic and antiserotonin activities. Kumbar M NIDA Res Monogr; 1978; (22):374-407. PubMed ID: 101885 [No Abstract] [Full Text] [Related]
28. [Research on the central activity and analgesia of N-substituted analogs of the amphetamine derivative 3,4-methylenedioxyphenylisopropylamine]. Braun U; Shulgin AT; Braun G Arzneimittelforschung; 1980; 30(5):825-30. PubMed ID: 7190428 [TBL] [Abstract][Full Text] [Related]
29. 6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency. Uyeno ET Proc West Pharmacol Soc; 1969; 12():118-23. PubMed ID: 4980529 [No Abstract] [Full Text] [Related]
30. Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines. De Jong AP; Huggins F; Fournier D; Makriyannis A Eur J Pharmacol; 1982 Sep; 83(3-4):305-8. PubMed ID: 7173311 [No Abstract] [Full Text] [Related]
31. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. Nichols DE J Psychoactive Drugs; 1986; 18(4):305-13. PubMed ID: 2880944 [No Abstract] [Full Text] [Related]
32. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model. Rusterholz DB; Spratt JL; Long JP; Barfknecht CF Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329 [No Abstract] [Full Text] [Related]
33. The hallucinogenic world of tryptamines: an updated review. Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327 [TBL] [Abstract][Full Text] [Related]
34. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters. Clare BW J Med Chem; 1990 Feb; 33(2):687-702. PubMed ID: 2299636 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats. Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910 [TBL] [Abstract][Full Text] [Related]
36. On the conformations of hallucinogenic molecules and their correlation. Chothia C; Pauling P Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1063-70. PubMed ID: 4311249 [TBL] [Abstract][Full Text] [Related]
37. Effect of 4-substitution on psychotomimetic activity of 2,5-dimethoxy amphetamines as studied by means of different substituent parameter scales. Neuvonen K; Neuvonen H; Fülöp F Bioorg Med Chem Lett; 2006 Jul; 16(13):3495-8. PubMed ID: 16644223 [TBL] [Abstract][Full Text] [Related]
38. Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues. Domelsmith LN; Eaton TA; Houk KN; Anderson GM; Glennon RA; Shulgin AT; Castagnoli N; Kollman PA J Med Chem; 1981 Dec; 24(12):1414-21. PubMed ID: 7310818 [TBL] [Abstract][Full Text] [Related]
39. Molecular orbital studies on the conformation of hallucinogenic indolealkylamines and related compounds. The isolated molecules and the solvent effect. Pullman B; Courrière P; Berthod H J Med Chem; 1974 Apr; 17(4):439-47. PubMed ID: 4524607 [No Abstract] [Full Text] [Related]
40. Benzofuran bioisosteres of hallucinogenic tryptamines. Tomaszewski Z; Johnson MP; Huang X; Nichols DE J Med Chem; 1992 May; 35(11):2061-4. PubMed ID: 1534585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]